AVAH
Income statement / Annual
Last year (2023), Aveanna Healthcare Holdings Inc.'s total revenue was $1.90 B,
an increase of 6.02% from the previous year.
In 2023, Aveanna Healthcare Holdings Inc.'s net income was -$134.52 M.
See Aveanna Healthcare Holdings Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/30/2023 |
12/31/2022 |
01/01/2022 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$1.90 B
|
$1.79 B
|
$1.68 B
|
$1.50 B
|
$1.38 B
|
$1.25 B
|
| Cost of Revenue |
$1.30 B |
$1.23 B |
$1.14 B |
$1.04 B |
$964.81 M |
$859.35 M |
| Gross Profit |
$595.43 M |
$553.23 M |
$542.40 M |
$454.52 M |
$419.25 M |
$394.32 M |
| Gross Profit Ratio |
0.31 |
0.31 |
0.32 |
0.3 |
0.3 |
0.31 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$464.74 M
|
$483.95 M
|
$427.77 M
|
$354.77 M
|
$341.00 M
|
$321.84 M
|
| Selling & Marketing
Expenses |
$8.57 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$473.30 M
|
$483.95 M
|
$427.77 M
|
$354.77 M
|
$341.00 M
|
$321.84 M
|
| Other Expenses |
$114.06 M |
$36.11 M |
$20.21 M |
$17.94 M |
$16.64 M |
-$13.74 M |
| Operating Expenses |
$587.36 M |
$520.06 M |
$447.98 M |
$372.71 M |
$357.64 M |
$339.71 M |
| Cost And Expenses |
$1.89 B |
$1.75 B |
$1.58 B |
$1.41 B |
$1.32 B |
$1.20 B |
| Interest Income |
$327,000.00 |
$679,000.00 |
$253,000.00 |
$345,000.00 |
$207,000.00 |
$594,000.00 |
| Interest Expense |
$153.25 M |
$99.94 M |
$68.93 M |
$82.98 M |
$92.30 M |
$75.54 M |
| Depreciation &
Amortization |
$30.10 M
|
$38.82 M
|
$35.39 M
|
$30.22 M
|
$27.01 M
|
$11.94 M
|
| EBITDA |
$44.35 M
|
-$517.28 M
|
-$9.26 M
|
$22.13 M
|
$44.28 M
|
$96.11 M
|
| EBITDA Ratio |
0.02 |
0.04 |
0.08 |
0.08 |
0.05 |
0.04 |
| Operating Income Ratio
|
0
|
0.01
|
0.06
|
0.05
|
0.03
|
0.03
|
| Total Other
Income/Expenses Net |
-$147.07 M
|
-$21.54 M
|
-$77.47 M
|
-$48.25 M
|
-$113.98 M
|
-$88.69 M
|
| Income Before Tax |
-$139.00 M |
-$663.81 M |
-$113.58 M |
-$51.73 M |
-$75.03 M |
-$49.66 M |
| Income Before Tax Ratio
|
-0.07
|
-0.37
|
-0.07
|
-0.03
|
-0.05
|
-0.04
|
| Income Tax Expense |
-$4.47 M |
-$1.78 M |
$3.47 M |
$5.32 M |
$1.49 M |
-$2.51 M |
| Net Income |
-$134.52 M |
-$662.03 M |
-$117.04 M |
-$57.05 M |
-$76.52 M |
-$47.15 M |
| Net Income Ratio |
-0.07 |
-0.37 |
-0.07 |
-0.04 |
-0.06 |
-0.04 |
| EPS |
-0.71 |
-3.57 |
-0.63 |
-0.31 |
-0.41 |
-0.26 |
| EPS Diluted |
-0.71 |
-3.57 |
-0.63 |
-0.31 |
-0.41 |
-0.26 |
| Weighted Average Shares
Out |
$189.96 M
|
$185.55 M
|
$184.73 M
|
$185.90 M
|
$185.90 M
|
$180.16 M
|
| Weighted Average Shares
Out Diluted |
$189.96 M
|
$185.55 M
|
$184.73 M
|
$185.90 M
|
$185.90 M
|
$180.16 M
|
| Link |
|
|
|
|
|
|
